Plant Comparison
Horse Chestnut vs Witch Hazel
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Horse Chestnut and Witch Hazel: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), haemorrhoids, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Horse Chestnut | Witch Hazel | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 5/10 | Stronger for Witch Hazel |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Haemorrhoids | 2/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 5/10 | Stronger for Witch Hazel |
| Skin irritation | 2/10 | 5/10 | Stronger for Witch Hazel |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The active mixture responsible for the venotonic and anti-oedematous effects; extracts are standardised to it. Escin is available as oral drages and a transdermal gel, with efficacy shown in chronic venous insufficiency and blunt-trauma injury.
The principal astringent and anti-inflammatory constituents.
Antioxidant and anti-inflammatory constituents of the bark and leaf.
Pharmacological Actions
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Escin, the triterpene saponin of Aesculus hippocastanum, induces apoptosis and cell-cycle arrest and chemosensitizes breast, hepatocellular, lung and pancreatic cancer cells (preclinical, including in vivo xenograft models).
Anti-inflammatory and antioxidant (supports irritated/atopic skin); Relief of haemorrhoid symptoms (astringent and anti-inflammatory)
Astringent for skin irritation and minor inflammation of the skin and oral mucosa (tannins), applied topically; Relief of haemorrhoid symptoms (astringent and anti-inflammatory)
Traditional & Indicated Uses
inferred from anti-inflammatory action
Escin shows antiproliferative and pro-apoptotic activity and enhances chemotherapy/immunotherapy efficacy in breast (MCF-7), hepatocellular, lung and pancreatic cancer models; it modulates NF-kappaB, p53, p38 MAPK/ERK and PD-L1 (preclinical).
Relief of haemorrhoid symptoms (venotonic)
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
inferred from anti-inflammatory action
Vulnerary for minor wounds, bruises and insect bites
inferred from anticancer action
Relief of haemorrhoid symptoms (astringent and anti-inflammatory)
Astringent for skin irritation and minor inflammation of the skin and oral mucosa (tannins), applied topically
Astringent for skin irritation and minor inflammation of the skin and oral mucosa (tannins), applied topically
Astringent for skin irritation and minor inflammation of the skin and oral mucosa (tannins), applied topically
Safety, Cautions & Contraindications
Use only standardised, processed seed extract. Raw conkers, leaves and bark contain toxic esculin and can cause poisoning - never eat raw horse chestnut.
May increase bleeding risk, so use caution with anticoagulant/antiplatelet medicines; use caution in kidney disease and avoid in pregnancy and breastfeeding.
For topical use. Do not apply to deep wounds, serious burns or severe rectal bleeding - these need medical care.
External Ids
Botanical Description
Large deciduous tree, to 25-30 m, with a broad domed crown and stout, upward-arching branches. The leaves are opposite and palmately compound, with five to seven large, obovate, toothed leaflets radiating from a long stalk. In spring the tree bears large, showy, upright pyramidal flower spikes ('candles') of white flowers marked with yellow or pink at the base. The glossy brown seeds ('conkers') develop inside a spiky green husk and fall in autumn.[1]
Large, multi-stemmed deciduous shrub or small tree with broad, oval, wavy-toothed leaves, asymmetrical at the base. Unusually, it flowers in late autumn to winter after the leaves have fallen, bearing clusters of small, spidery, bright yellow flowers with narrow, crinkled, ribbon-like petals. The woody seed capsule matures the following autumn and explosively ejects its seeds ('snapping hazelnut').[14]
Habitat
Harvesting
Bark is stripped from branches (not the main trunk, to avoid harming the plant) and leaves are picked in summer; both are dried for use, or steam-distilled together with twigs to produce distilled witch-hazel water, the most common commercial form.[14]
Traditional Uses
Horse chestnut seed has a long folk history as a remedy for varicose veins, haemorrhoids and 'heavy legs', and was also used topically for rheumatic pain and bruising. Modern use is almost exclusively as a standardised seed extract for chronic venous insufficiency, confirming this traditional venous-support reputation.[1]
Witch hazel has a long Native American and, after adoption by European settlers, worldwide reputation as a topical astringent and anti-inflammatory remedy for skin irritation, minor wounds, bruises, insect bites and haemorrhoids, and as a soothing wash for irritated skin and mucous membranes.[14]
Preparations
Dosage
Clinical studies commonly use extracts standardised to around 100-150 mg escin daily, in divided doses. Educational reference only, not a prescription.
The EU herbal monograph gives semi-solid dosage forms containing the equivalent of 0.4% triterpene glycosides calculated as protoaescigenin (or, depending on the preparation, 0.85-20% herbal preparation), applied as a thin layer to the affected area 1-3 times daily, in adults and elderly. Educational reference only, not a prescription.
The EU herbal monograph on Hamamelis virginiana L., cortex gives, for cutaneous use, tincture at a strength corresponding to 5-10% in semi-solid preparations several times daily, or a dry extract (5-7.7:1, ethanol 30% m/m) at a strength corresponding to 1.3% as an ointment several times daily; for anorectal use, a decoction of 5-10 g per 250 mL up to 3 times daily as impregnated dressings. For topical use only. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Idris, S. and Mishra, A. and Khushtar, M (2020) 'Phytochemical, ethnomedicinal and pharmacological applications of escin from Aesculus hippocastanum L. towards future medicine', Journal of Basic and Clinical Physiology and Pharmacology, 31(5). doi:10.1515/jbcpp-2019-0115 Meta-analysis / review
https://doi.org/10.1515/jbcpp-2019-0115 - Penaranda Figueredo, F.A. and Vicente, J. and Barquero, A.A. and Bueno, C.A (2024) 'Aesculus hippocastanum extract and the main bioactive constituent beta-escin as antivirals agents against coronaviruses, including SARS-CoV-2', Scientific Reports, 14(1), pp. 6418. doi:10.1038/s41598-024-56759-y Preclinical
https://doi.org/10.1038/s41598-024-56759-y - Idris, S. and Mishra, A. and Khushtar, M (2023) 'Phytochemical Estimation and Therapeutic Amelioration of Aesculus hippocastanum L. Seeds Ethanolic Extract in Gastric Ulcer in Rats Possibly by Inhibiting Prostaglandin Synthesis', Chinese Journal of Integrative Medicine, 29(9), pp. 818-824. doi:10.1007/s11655-023-3734-9 Preclinical
https://doi.org/10.1007/s11655-023-3734-9 - Quarta, S. and Santarpino, G. and Carluccio, M.A. and Calabriso, N. and Scoditti, E. and Siculella, L. and Damiano, F. and Maffia, M. and Verri, T. and De Caterina, R. and Massaro, M (2022) 'Analysis of the Anti-Inflammatory and Anti-Osteoarthritic Potential of Flonat Fast, a Combination of Plant Extracts, Bromelain and Escin (Aesculus hippocastanum), Evaluated in In Vitro Models of Inflammation Relevant to Osteoarthritis', Pharmaceuticals, 15(10), pp. 1263. doi:10.3390/ph15101263 Preclinical
https://doi.org/10.3390/ph15101263 - Owczarek, A. and Kolodziejczyk-Czepas, J. and Wozniak-Serwata, J. and Magiera, A. and Kobiela, N. and Wasowicz, K. and Olszewska, M.A (2021) 'Potential Activity Mechanisms of Aesculus hippocastanum Bark: Antioxidant Effects in Chemical and Biological In Vitro Models', Antioxidants, 10(7), pp. 995. doi:10.3390/antiox10070995 Preclinical
https://doi.org/10.3390/antiox10070995 - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Pittler, M.H. and Ernst, E (2012) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD003230.pub4 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub4 - Gallelli, L (2019) 'Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties', Drug Design, Development and Therapy, pp. 3425--3437. doi:10.2147/DDDT.S207720 Preclinical
https://doi.org/10.2147/DDDT.S207720 - Wu, X.J., Zhang, M.L., Cui, X.Y., Gao, F., He, Q., Li, X.J., Zhang, J.W., Fawcett, J.P. and Gu, J.K (2011) 'Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat', Journal of Ethnopharmacology, 139(1), pp. 201--206. doi:10.1016/j.jep.2011.11.003 Preclinical
https://doi.org/10.1016/j.jep.2011.11.003 - European Medicines Agency (HMPC) (2023) 'European Union herbal monograph on Aesculus hippocastanum L., semen, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters, pp. 1--8. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Mazrouei, R. and Raeisi, E. and Lemoigne, Y. and Heidarian, E (2019) 'Activation of p53 Gene Expression and Synergistic Antiproliferative Effects of 5-Fluorouracil and beta-escin on MCF7 Cells', Journal of Medical Signals and Sensors, 9(3), pp. 196-203. doi:10.4103/jmss.JMSS_44_18 Preclinical
https://doi.org/10.4103/jmss.JMSS_44_18 - Yuan, Y. and Wang, P. and Chen, S. and Cao, Z. and Ojha, S.C. and Sun, C. and Wang, G. and Wang, Z. and Gu, J. and Kang, J. and Xue, X (2025) 'Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma', Phytomedicine, 149, pp. 157532. doi:10.1016/j.phymed.2025.157532 Preclinical
https://doi.org/10.1016/j.phymed.2025.157532 - Hussain, Y. and Singh, J. and Meena, A. and Sinha, R.A. and Luqman, S (2023) 'Escin enhanced the efficacy of sorafenib by autophagy-mediated apoptosis in lung cancer cells', Phytotherapy Research, 37(10), pp. 4819-4837. doi:10.1002/ptr.7948 Preclinical
https://doi.org/10.1002/ptr.7948 - Rimmon, A. and Vexler, A. and Berkovich, L. and Earon, G. and Ron, I. and Lev-Ari, S (2013) 'Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway', Biochemistry Research International, 2013, pp. 251752. doi:10.1155/2013/251752 Preclinical
https://doi.org/10.1155/2013/251752 - Domanski, D., Zegrocka-Stendel, O., Perzanowska, A., Dutkiewicz, M., Kowalewska, M., Grabowska, I., Maciejko, D., Fogtman, A., Dadlez, M. and Koziak, K (2016) 'Molecular Mechanism for Cellular Response to beta-Escin and Its Therapeutic Implications', PLoS One, 11(10). doi:10.1371/journal.pone.0164365 Preclinical
https://doi.org/10.1371/journal.pone.0164365 - Gloviczki, M.L., Kakkos, S.K., Urbanek, T., Chuback, J. and Nicolaides, A (2025) 'The role of venoactive compounds in the treatment of chronic venous disease', Journal of Vascular Surgery: Venous and Lymphatic Disorders, 13(5). doi:10.1016/j.jvsv.2025.102258 Preclinical
https://doi.org/10.1016/j.jvsv.2025.102258 - Santiago, F.R., Grillo, L., Amore, M., Carmelino, C., Trejo, J.M.R. and Ulloa, J.H (2026) 'Venoactive drugs in the management of chronic venous disease: A critical appraisal of the evidence and comparison with international guidelines', Vascular Pharmacology. doi:10.1016/j.vph.2026.107614 Preclinical
https://doi.org/10.1016/j.vph.2026.107614 - Pittler, M.H. and Ernst, E (2006) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews, 2006(1), pp. CD003230. doi:10.1002/14651858.CD003230.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub3
- Skowrońska, W., Pawłowska, K.A., Obrębski, M., Piwowarski, J.P. et al (2025) 'Chemical composition, skin microbiota metabolism, antimicrobial potential and anti-inflammatory properties of witch hazel bark (Hamamelis virginiana L.)', Journal of Ethnopharmacology, 353(Pt B), pp. 120433. doi:10.1016/j.jep.2025.120433 Preclinical
https://doi.org/10.1016/j.jep.2025.120433 - Piazza, S., Martinelli, G., Vrhovsek, U., Masuero, D. et al (2022) 'Anti-Inflammatory and Anti-Acne Effects of Hamamelis virginiana Bark in Human Keratinocytes', Antioxidants (Basel), 11(6), pp. 1119. doi:10.3390/antiox11061119 Preclinical
https://doi.org/10.3390/antiox11061119 - Janarthanam, V.A., Rajan, P.S.S., Panda, S.P., Panigrahy, U.P. et al (2025) 'Hamamelitannin from Hamamelis virginiana Attenuates Ethanol-Induced Oxidative and Inflammatory Responses in Danio rerio Larvae', Molecular Biotechnology, 68(5), pp. 2369-2385. doi:10.1007/s12033-025-01502-9 Preclinical
https://doi.org/10.1007/s12033-025-01502-9 - Piazza, S., Martinelli, G., Magnavacca, A., Fumagalli, M., Pozzoli, C., Terno, M., Canilli, L., Angarano, M., Maranta, N., Dell'Agli, M. and Sangiovanni, E (2022) 'Unveiling the Ability of Witch Hazel (Hamamelis virginiana L.) Bark Extract to Impair Keratinocyte Inflammatory Cascade Typical of Atopic Eczema', International Journal of Molecular Sciences, 23(16), pp. 9279. doi:10.3390/ijms23169279 Preclinical
https://doi.org/10.3390/ijms23169279 - Amendola, I., Viegas, D.J., Freitas, E.T., Oliveira, J.R., Santos, J.G., Oliveira, F.E., Lagareiro Netto, A.A., Marcucci, M.C., Oliveira, L.D. and Back-Brito, G.N (2024) 'Hamamelis virginiana L. extract presents antimicrobial and antibiofilm effects, absence of cytotoxicity, anti-inflammatory action, and potential to fight infections through the nitric oxide production by macrophages', Anais da Academia Brasileira de Ciencias, 96(1), pp. e20200031. doi:10.1590/0001-3765202320200031 Preclinical
https://doi.org/10.1590/0001-3765202320200031 - Habtemariam, S (2002) 'Hamamelitannin from Hamamelis virginiana inhibits the tumour necrosis factor-alpha (TNF)-induced endothelial cell death in vitro', Toxicon, 40(1), pp. 83-88. doi:10.1016/s0041-0101(01)00195-7 Preclinical
https://doi.org/10.1016/s0041-0101(01)00195-7 - Natella, F., Guantario, B., Ambra, R., Ranaldi, G., Intorre, F., Burki, C. and Canali, R (2021) 'Human Metabolites of Hamamelis virginiana (Extract) Modulate Fibroblast Extracellular Matrix Components in Response to UV-A Irradiation', Frontiers in Pharmacology, 12, pp. 747638. doi:10.3389/fphar.2021.747638 Randomized trial
https://doi.org/10.3389/fphar.2021.747638 - Dauer, A., Rimpler, H. and Hensel, A (2003) 'Polymeric proanthocyanidins from the bark of Hamamelis virginiana', Planta Medica, 69(1), pp. 89-91. doi:10.1055/s-2003-37022 Preclinical
https://doi.org/10.1055/s-2003-37022 - Vennat, B., Pourrat, H., Pouget, M.P., Gross, D. and Pourrat, A (1988) 'Tannins from Hamamelis virginiana: identification of proanthocyanidins and hamamelitannin quantification in leaf, bark, and stem extracts', Planta Medica, 54(5), pp. 454-457. doi:10.1055/s-2006-962499 Preclinical
https://doi.org/10.1055/s-2006-962499 - Duckstein, S.M., Lorenz, P. and Stintzing, F.C (2012) 'Conversion of phenolic constituents in aqueous Hamamelis virginiana leaf extracts during fermentation', Phytochemical Analysis, 23(6), pp. 588-597. doi:10.1002/pca.2359 Preclinical
https://doi.org/10.1002/pca.2359 - Sanchez-Tena, S., Fernandez-Cachon, M.L., Carreras, A., Mateos-Martin, M.L., Costoya, N., Moyer, M.P., Nunez, M.J., Torres, J.L. and Cascante, M (2012) 'Hamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells', Journal of Natural Products, 75(1), pp. 26-33. doi:10.1021/np200426k Preclinical
https://doi.org/10.1021/np200426k - Theisen, L.L., Erdelmeier, C.A.J., Spoden, G.A., Boukhallouk, F., Sausy, A., Florin, L. and Muller, C.P (2014) 'Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus', PLoS One, 9(1), pp. e88062. doi:10.1371/journal.pone.0088062 Preclinical
https://doi.org/10.1371/journal.pone.0088062 - Cheesman, M.J., Alcorn, S.R., White, A. and Cock, I.E (2023) 'Hamamelis virginiana L. Leaf Extracts Inhibit the Growth of Antibiotic-Resistant Gram-Positive and Gram-Negative Bacteria', Antibiotics, 12(7), pp. 1195. doi:10.3390/antibiotics12071195 Preclinical
https://doi.org/10.3390/antibiotics12071195 - European Medicines Agency (HMPC) (n.d.) 'European Union herbal monograph on Hamamelis virginiana L., cortex/folium/aqua (Hamamelidis cortex)'. Available at: https://www.ema.europa.eu/en/medicines/herbal/hamamelidis-cortex Traditional / reference
https://www.ema.europa.eu/en/medicines/herbal/hamamelidis-cortex - (2025) 'Hamamelis virginiana L. in Skin Care: A Review of Its Pharmacological Properties and Cosmetological Applications', Molecules. doi:10.3390/molecules30132744 Randomized trial
https://doi.org/10.3390/molecules30132744 - Herbal Reality (n.d.) 'Witch Hazel (Hamamelis virginiana): Benefits, Safety, Uses'. Available at: https://www.herbalreality.com/herb/witch-hazel/ Traditional / reference
https://www.herbalreality.com/herb/witch-hazel/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.